Literature DB >> 16611388

Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.

A Greyling1, C De Witt, W Oosthuizen, J C Jerling.   

Abstract

Policosanol is a mixture of higher aliphatic primary alcohols that is extracted from purified sugar cane wax or a variety of other plant sources, and has been shown to have beneficial effects on serum lipid concentrations. The objective of this study was to investigate the effects of a policosanol supplement (Octa-60) on lipid profiles of hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Nineteen hypercholesterolaemic and familial hypercholesterolaemic subjects completed this randomised, placebo-controlled, double-blind study. The subjects received either a daily dose of 20 mg policosanol or placebo for 12 weeks. After a wash-out period of 4 weeks, the interventions were crossed over. Lipid levels were measured at baseline and at the end of each intervention period. No significant differences in total cholesterol and LDL-cholesterol from baseline to end or between policosanol and placebo were seen in the hypercholesterolaemic or familial hypercholesterolaemic groups. There were small reductions in total cholesterol and LDL-cholesterol from baseline to end in the hypercholesterolaemic group, but these changes did not differ significantly from the changes with the placebo, indicating that the observed decrease in cholesterol in the policosanol group was not due to the specific effect of policosanol treatment. The differences in response may be ascribed to the differences in composition of the higher aliphatic primary alcohols in the previously used products, compared with the local policosanol supplement. An intake of 20 mg/d policosanol for 12 weeks had no significant effect on serum lipid levels in hypercholesterolaemic and heterozygous familial hypercholesterolaemic patients when compared with placebo intake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611388     DOI: 10.1079/bjn20061715

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  11 in total

1.  Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.

Authors:  Barbara Swanson; Joyce K Keithley; Beverly E Sha; Louis Fogg; Judith Nerad; Richard M Novak; Oluwatoyin Adeyemi; Gregory T Spear
Journal:  Altern Ther Health Med       Date:  2011 Mar-Apr       Impact factor: 1.305

2.  Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy.

Authors:  James M Backes; Cheryl A Gibson; Janelle F Ruisinger; Patrick M Moriarty
Journal:  Lipids       Date:  2011-07-08       Impact factor: 1.880

3.  Letters.

Authors:  Alan Gaby
Journal:  Integr Med (Encinitas)       Date:  2021-10

4.  Octacosanol administration to humans decreases neutral sterol and bile acid concentration in feces.

Authors:  Sylvia Keller; Franziska Gimmler; Gerhard Jahreis
Journal:  Lipids       Date:  2007-11-15       Impact factor: 1.880

5.  Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects.

Authors:  Jae-Yong Kim; Seong-Min Kim; Suk-Jeong Kim; Eun-Young Lee; Jae-Ryong Kim; Kyung-Hyun Cho
Journal:  Int J Mol Med       Date:  2017-02-24       Impact factor: 4.101

6.  Potential role of phytochemicals in metabolic syndrome prevention and therapy.

Authors:  Francesco Francini-Pesenti; Paolo Spinella; Lorenzo A Calò
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-01       Impact factor: 3.168

7.  Impact of Diet on Plasma Lipids in Individuals with Heterozygous Familial Hypercholesterolemia: A Systematic Review of Randomized Controlled Nutritional Studies.

Authors:  Gabrielle Roy; Anykim Boucher; Patrick Couture; Jean-Philippe Drouin-Chartier
Journal:  Nutrients       Date:  2021-01-15       Impact factor: 5.717

8.  Changes in cholesterol kinetics following sugar cane policosanol supplementation: a randomized control trial.

Authors:  Amira N Kassis; Peter J H Jones
Journal:  Lipids Health Dis       Date:  2008-04-30       Impact factor: 3.876

9.  Characterization of rice bran wax policosanol and its nanoemulsion formulation.

Authors:  Aminu Ishaka; Mustapha Umar Imam; Rozi Mahamud; Abu Bakar Zakaria Zuki; Ismail Maznah
Journal:  Int J Nanomedicine       Date:  2014-05-09

10.  Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy.

Authors:  Milica Zrnic Ciric; Miodrag Ostojic; Ivana Baralic; Jelena Kotur-Stevuljevic; Brizita I Djordjevic; Stana Markovic; Stefan Zivkovic; Ivan Stankovic
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.